𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CMR 2005: 3.01: MRI tumor characterization using Gd–GlyMe–DOTA-perfluorooctylmannose conjugate (Gadofluorine M), a novel protein-avid contrast agent

✍ Scribed by R. Brasch; H.-J. Raatschen; Z. Boyd; D. Shames; M. Zierhut; R. Swain; B. Misselwitz; H. Weinmann; M. Wendland

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
43 KB
Volume
1
Category
Article
ISSN
1555-4309

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MRI tumor characterization using Gd-GlyM
MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctyl-mannose-conjugate (Gadofluorine M™), a protein-avid contrast agent
✍ Hans-Jürgen Raatschen; Rebecca Swain; David M. Shames; Yanjun Fu; Zachary Boyd; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

## Abstract The rationale and objectives were to define the MRI tumor‐characterizing potential of a new protein‐avid contrast agent, Gd‐GlyMe‐DOTA‐perfluorooctyl‐mannose‐conjugate (Gadofluorine M™; Schering AG, Berlin, Germany) in a chemically induced tumor model of varying malignancy. Because of t